PrEP on the spot: new study tests HIV prevention at syringe programs
NCT ID NCT04782180
First seen Dec 31, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tested whether offering HIV prevention medicine (PrEP) right away at a syringe services program helps people stay HIV-negative. 90 adults who were already enrolled in the program and tested negative for HIV took part. Researchers measured drug levels in the blood to check adherence and how quickly people started PrEP after their negative test.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.